De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial
Titel:
De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial
Auteur:
Clark, Richard E Polydoros, Fotios Apperley, Jane F Milojkovic, Dragana Pocock, Christopher Smith, Graeme Byrne, Jenny L de Lavallade, Hugues O'Brien, Stephen G Coffey, Tony Foroni, Letizia Copland, Mhairi